Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterochromaffin cells are a specialized neuroendocrine cell type within the intestinal epithelium, primarily responsible for producing and secreting serotonin (5-hydroxytryptamine, 5-HT), which mediates gut motility, secretion, and visceral sensation[1][2][3][6][7][9]. These cells act as luminal sensory transducers, responding to mechanical, chemical, and microbial signals by releasing serotonin that acts in a paracrine or endocrine fashion on neighboring nerve fibers and other target cells[2][4][6][8][9]. While not themselves a single canonical therapeutic target like a specific receptor or enzyme, their activity and serotonin output are therapeutically modulated via drugs targeting 5-HT receptors to treat gastrointestinal disorders such as IBS[2][3][4]. EC cells also interact with gut microbiota and immune pathways and are implicated in multiple GI, metabolic, and inflammatory diseases[1][3][7][8]. **Note:** "Enterochromaffin cell activity" is not a canonical molecular target but instead refers to the physiological function of a cell population. Drugs modulate their function indirectly by targeting downstream 5-HT (serotonin) receptors or via other signaling pathways. Therefore, this entry is marked as "is_incorrect: true" for target nomenclature.
5-HT3 receptor antagonism (e.g., alosetron), 5-HT4 receptor agonism (e.g., tegaserod), Somatostatin-mediated inhibition of serotonin release
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterochromaffin cell (EC cell).